Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
AUGM-101
/
1E Therap
Welcome,
Profile
Billing
Logout
Diseases
Trials
Trials
News
|
|||||||||
AUGM-101
/
1E Therap
New P1/2 trial:
In This Study AUGM-101 Will be Assessed for Its Safety, Tolerability, Pharmacokinetic and Pharmacodynamic in Healthy Volunteers and COVID-19-infected Patients
(clinicaltrials.gov) - Jul 14, 2021
P1/2
, N=104, Recruiting,
Sponsor: 1E Therapeutics